Avinger Announces Second Quarter 2017 Results

Published: Aug 09, 2017

REDWOOD CITY, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended June 30, 2017.

Second Quarter and Recent Highlights

Executed strategic reorganization in April, reducing sales headcount by approximately 50% and resulting in a significant reduction in cash usage

Back to news